243 related articles for article (PubMed ID: 27015368)
1. The retinoblastoma protein regulates hypoxia-inducible genetic programs, tumor cell invasiveness and neuroendocrine differentiation in prostate cancer cells.
Labrecque MP; Takhar MK; Nason R; Santacruz S; Tam KJ; Massah S; Haegert A; Bell RH; Altamirano-Dimas M; Collins CC; Lee FJ; Prefontaine GG; Cox ME; Beischlag TV
Oncotarget; 2016 Apr; 7(17):24284-302. PubMed ID: 27015368
[TBL] [Abstract][Full Text] [Related]
2. A TRIP230-retinoblastoma protein complex regulates hypoxia-inducible factor-1α-mediated transcription and cancer cell invasion.
Labrecque MP; Takhar MK; Jagdeo JM; Tam KJ; Chiu C; Wang TY; Prefontaine GG; Cox ME; Beischlag TV
PLoS One; 2014; 9(6):e99214. PubMed ID: 24919196
[TBL] [Abstract][Full Text] [Related]
3. Annexin-A7 protects normal prostate cells and induces distinct patterns of RB-associated cytotoxicity in androgen-sensitive and -resistant prostate cancer cells.
Torosyan Y; Simakova O; Naga S; Mezhevaya K; Leighton X; Diaz J; Huang W; Pollard H; Srivastava M
Int J Cancer; 2009 Dec; 125(11):2528-39. PubMed ID: 19610065
[TBL] [Abstract][Full Text] [Related]
4. REST reduction is essential for hypoxia-induced neuroendocrine differentiation of prostate cancer cells by activating autophagy signaling.
Lin TP; Chang YT; Lee SY; Campbell M; Wang TC; Shen SH; Chung HJ; Chang YH; Chiu AW; Pan CC; Lin CH; Chu CY; Kung HJ; Cheng CY; Chang PC
Oncotarget; 2016 May; 7(18):26137-51. PubMed ID: 27034167
[TBL] [Abstract][Full Text] [Related]
5. Wnt-11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cells.
Uysal-Onganer P; Kawano Y; Caro M; Walker MM; Diez S; Darrington RS; Waxman J; Kypta RM
Mol Cancer; 2010 Mar; 9():55. PubMed ID: 20219091
[TBL] [Abstract][Full Text] [Related]
6. ING3 is associated with increased cell invasion and lethal outcome in ERG-negative prostate cancer patients.
Almami A; Hegazy SA; Nabbi A; Alshalalfa M; Salman A; Abou-Ouf H; Riabowol K; Bismar TA
Tumour Biol; 2016 Jul; 37(7):9731-8. PubMed ID: 26803516
[TBL] [Abstract][Full Text] [Related]
7. The role of tumor suppressor dysregulation in prostate cancer progression.
Dean JL; Knudsen KE
Curr Drug Targets; 2013 Apr; 14(4):460-71. PubMed ID: 23410128
[TBL] [Abstract][Full Text] [Related]
8. Differential requirements for ras and the retinoblastoma tumor suppressor protein in the androgen dependence of prostatic adenocarcinoma cells.
Fribourg AF; Knudsen KE; Strobeck MW; Lindhorst CM; Knudsen ES
Cell Growth Differ; 2000 Jul; 11(7):361-72. PubMed ID: 10939590
[TBL] [Abstract][Full Text] [Related]
9. Retinoblastoma protein (Rb) links hypoxia to altered mechanical properties in cancer cells as measured by an optical tweezer.
Khakshour S; Labrecque MP; Esmaeilsabzali H; Lee FJS; Cox ME; Park EJ; Beischlag TV
Sci Rep; 2017 Aug; 7(1):7833. PubMed ID: 28798482
[TBL] [Abstract][Full Text] [Related]
10. SRC family kinase FYN promotes the neuroendocrine phenotype and visceral metastasis in advanced prostate cancer.
Gururajan M; Cavassani KA; Sievert M; Duan P; Lichterman J; Huang JM; Smith B; You S; Nandana S; Chu GC; Mink S; Josson S; Liu C; Morello M; Jones LW; Kim J; Freeman MR; Bhowmick N; Zhau HE; Chung LW; Posadas EM
Oncotarget; 2015 Dec; 6(42):44072-83. PubMed ID: 26624980
[TBL] [Abstract][Full Text] [Related]
11. The Vav3 oncogene enhances the malignant potential of prostate cancer cells under chronic hypoxia.
Hirai K; Nomura T; Yamasaki M; Inoue T; Narimatsu T; Chisato Nakada PD; Yoshiyuki Tsukamoto PD; Matsuura K; Sato F; Moriyama M; Mimata H
Urol Oncol; 2014 Feb; 32(2):101-9. PubMed ID: 23403204
[TBL] [Abstract][Full Text] [Related]
12. Identification of a genetic interaction between the tumor suppressor EAF2 and the retinoblastoma protein (Rb) signaling pathway in C. elegans and prostate cancer cells.
Cai L; Wang D; Fisher AL; Wang Z
Biochem Biophys Res Commun; 2014 May; 447(2):292-8. PubMed ID: 24727455
[TBL] [Abstract][Full Text] [Related]
13. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
[TBL] [Abstract][Full Text] [Related]
14. The molecular basis of cancer suppression by the retinoblastoma gene.
Lee WH
Princess Takamatsu Symp; 1989; 20():159-70. PubMed ID: 2488231
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-independent downregulation of hypoxia-inducible factor 1 targets by androgen deprivation therapy in prostate cancer.
Ragnum HB; Røe K; Holm R; Vlatkovic L; Nesland JM; Aarnes EK; Ree AH; Flatmark K; Seierstad T; Lilleby W; Lyng H
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):753-60. PubMed ID: 24035332
[TBL] [Abstract][Full Text] [Related]
16. Release of macrophage migration inhibitory factor by neuroendocrine-differentiated LNCaP cells sustains the proliferation and survival of prostate cancer cells.
Tawadros T; Alonso F; Jichlinski P; Clarke N; Calandra T; Haefliger JA; Roger T
Endocr Relat Cancer; 2013 Feb; 20(1):137-49. PubMed ID: 23207293
[TBL] [Abstract][Full Text] [Related]
17. The orexin type 1 receptor is overexpressed in advanced prostate cancer with a neuroendocrine differentiation, and mediates apoptosis.
Alexandre D; Hautot C; Mehio M; Jeandel L; Courel M; Voisin T; Couvineau A; Gobet F; Leprince J; Pfister C; Anouar Y; Chartrel N
Eur J Cancer; 2014 Aug; 50(12):2126-33. PubMed ID: 24910418
[TBL] [Abstract][Full Text] [Related]
18. Androgens repress Bcl-2 expression via activation of the retinoblastoma (RB) protein in prostate cancer cells.
Huang H; Zegarra-Moro OL; Benson D; Tindall DJ
Oncogene; 2004 Mar; 23(12):2161-76. PubMed ID: 14676836
[TBL] [Abstract][Full Text] [Related]
19. Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma.
Bookstein R; Rio P; Madreperla SA; Hong F; Allred C; Grizzle WE; Lee WH
Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7762-6. PubMed ID: 2217208
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of retinoblastoma tumor suppressor activity by RNA interference in lung cancer lines.
Reed MF; Zagorski WA; Howington JA; Zilfou JT; Knudsen ES
Ann Thorac Surg; 2006 Jul; 82(1):249-53. PubMed ID: 16798224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
